Bristol-Myers Squibb Co (NYSE: BMY) is inching up on Monday after announcing an $11 billion deal with BioNTech SE (Nasdaq: BNTX) aimed at transforming cancer treatment.The pharmaceutical behemoth announced the said partnership at ASCO, the world’s largest cancer conference in Chicago. Despite today’s price action, BMY shares are down some…
Singapore, which has historically depended on gas for its energy supply, is now exploring regional grid connections. The strategy primarily…
The Vietnamese Agriculture Ministry announced on Tuesday that domestic companies plan to sign memorandums of understanding with US partners…
The KOSPI Composite Index has embarked on a strong rally in the past few months as South Korean shares…
The Organization for Economic Cooperation and Development (OECD) has issued a stark warning, asserting that President Donald Trump’s aggressive…
Asia-Pacific stock markets concluded Tuesday’s trading session with a varied performance as investors digested a sharp contraction in China’s…
The EUR/USD exchange rate will be in the spotlight this week as the European Central Bank (ECB) delivers its…
Shaun Maguire, partner at Sequoia Capital, has expressed resounding confidence in SpaceX, calling it a once-in-a-generation company that is…
Wedbush analyst Dan Ives believes the AI boom will charge ahead at full throttle in the back half of…